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Abstract
Bacteriophages and bacterial biofilms are widely present in natural environ-
ments, a fact that has accelerated the evolution of phages and their bacterial
hosts in these particular niches. Phage-host interactions in biofilm commu-
nities are rather complex, where phages are not always merely predators
but also can establish symbiotic relationships that induce and strengthen
biofilms. In this review we provide an overview of the main features affect-
ing phage-biofilm interactions as well as the currently available methods
of studying these interactions. In addition, we address the applications of



























































































Most of the bacteria found in nature live in microbial communities called biofilms (1), where
the microbial cells are attached to a surface and encased in a self-producing matrix of extracel-
lular polymeric substances (EPSs) that confers on them an environment protected from hostile
conditions (2, 3). In turn, bacteriophages (phages), the natural predators of bacteria, are consid-
ered the predominant biological entities on earth and can be found in almost all ecological niches
where their host bacteria are present (4, 5). Although phages and biofilms have coexisted in natural
environments for millions of years, the complex interactions between them are far from fully un-
derstood. So far,most phage-bacteria studies are conducted in suspended cultures; in addition, the
biofilm studies that have been reported are usually performed under specific conditions that are
unable to mimic the high complexity of real biofilms found in nature or in health contexts (6).This
makes it difficult to draw conclusions about the impact biofilms may have had on phage evolution
over the years, as well as the role of phages in shaping the bacterial diversity in these particular
niches. Combining in vitro, ex vivo, or in vivo biofilm infection assays with computational simu-
lations can, however, help us to uncover and better understand the phage-biofilm interactions. In
this review, we address the mechanisms underlying phage-bacteria interactions in biofilm com-
munities, the possible methods of studying these interactions, and the potential applications of
phages for biofilm control in different contexts.
2. PHAGE-BIOFILM INTERACTION FROM MOLECULAR,
EVOLUTIONARY, AND ECOLOGICAL PERSPECTIVES
As biofilms are ubiquitous in nature, so are phages (1, 7). The coevolution between phages and
bacteria has been an important driver for the huge phenotypic and genotypic diversity found in
these microbial populations (8). Although biofilms can protect bacteria from harsh environmental
conditions and phage predation, phages can encode in their genomes EPS-degrading enzymes,
such as depolymerases, to obtain an advantage against these complex structures (9). On the other
hand, bacteria within biofilms have coevolved to find new counter-defense mechanisms, leading
to an endless arms race between phages and bacteria (8, 10–12). There is also growing evidence
that phages can promote biofilm formation and bring benefits to their bacterial hosts (13). All
of these aspects regarding phage-biofilm interactions are discussed below and are represented in
Figure 1.
2.1. How Biofilm Composition and Architecture Affect Phage Infection
It is well known that biofilm structure and composition can pose limitations on phage predation
(6). In addition to the biofilmmatrix that contributes to impairment of the diffusion of phages and
their propagation, other factors such as the low metabolic activity of biofilm cells, the presence of
secreted molecules that may act as phage decoys, or even the presence of more than one microbial
species in the biofilm may also contribute to an inefficient phage infection (6, 14).
Flemming & Wingender (15) estimated that in most biofilms, the EPS matrix accounts for
more than 90%of the biofilm drymass,whereas themicrobial cells account for less than 10%.This
EPS matrix—composed of polymeric substances and other secreted products including enzymes,
proteins, lipids, or nucleic acids—contributes to the cohesion of biofilms (15) and can cause phage
entrapment, acting as a physical barrier to phage diffusion and access to the bacterial cells, and
consequently preventing an efficient infection (16).
González et al. (17) studied the parameters that affected the diffusion and propagation of two
phages in Staphylococcus spp. biofilms. Although the authors confirmed that both phages could



















































































































Schematic representation of the features affecting phage-biofilm interaction. The biofilm is composed of the EPS matrix (light blue),
known to impair phage diffusion through the biofilm, and different types of bacterial cells: phage-susceptible and metabolically active
cells (green), dormant cells (dark green), and phage-resistant cells (red). The close proximity of biofilm cells may lead to more than one
phage infecting the same bacterial cell, resulting in reduced progeny. The secretion of OMVs or other molecules by the bacterial cells
may act as a decoy for phages that will bind to these molecules instead of the bacterial receptors. The release of signaling molecules by
bacteria can also influence the phage-host dynamics in the biofilm, as it can result in increased matrix production, changes in the
physiological state of the bacterial cells, and changes in cell wall receptors. The presence of clusters of resistant cells in the biofilm may
protect phage-sensitive cells from phage predation, and the induction of prophages may contribute to biofilm formation through the
release of biofilm-promoting agents (e.g., eDNA). However, phages may encode EPS-degrading enzymes in their genomes (e.g.,
depolymerases) or use biofilm channels to reach the target cells. Abbreviations: eDNA, extracellular DNA; EPS, extracellular polymeric
substance; OMV, outer membrane vesicle; QS, quorum sensing. Figure adapted from images created with BioRender.com.
diffuse through all the different biofilms tested, their data suggested that the diffusion rates of
phages within biofilms were influenced by several factors: the amount of biofilm biomass, the sus-
ceptibility of the bacterial strains to the phages, the phage concentration, and the composition of
the biofilm matrix that might contain phage-inactivating enzymes or components able to anchor
the phages (17). For instance, it is known that the outer membrane vesicles (OMVs) secreted
by some bacterial species can mediate phage entrapment in biofilms. These OMVs may contain
phage receptors, as observed for both Escherichia coli and Vibrio cholerae species (18, 19), which may
contribute to an irreversible binding of phages that will not be available to infect the biofilm cells.
The protective role of the biofilm matrix to phage predation was clearly demonstrated in a
recent study by Melo et al. (20) that assessed the interaction of a Staphylococcus epidermidis phage
with different biofilm-associated host cell populations. The observations of this study were cor-
roborated by confocal laser scanning microscopy (CLSM) data, which demonstrated that phage-
infected cells appeared only in certain regions of the biofilm where lower amounts of matrix were
present, evidencing that the biofilm matrix can serve as a shield to protect the embedded bacte-
ria from viral attack (20). In fact, the spatial organization of the biofilm can be a determinant to
the success of phage infection, as it may lead to limited mobility of cells that tend to organize
in localized niches with different nutrient availability (21). While the proximity of the cells in
these clusters might contribute to a decreased number of progeny phages as a result of multiple
phages infecting the same host cell (22), the nutrient gradients often lead to cells under different
metabolic states, including dormant or persister cells (6). It is known that phages require an active
machinery of the host to propagate, and consequently, their replication is strongly influenced by

























































































the physiological state of the host cell (23, 24). Therefore, so far only a few phages were reported
to have the capacity of infecting stationary-phase cells (25, 26). The number of biofilm cells with
reduced metabolic activity is expected to increase with biofilm age; consequently, older biofilms
(frequently found in nature) will be less susceptible to phages than younger biofilms (6).
Another important feature that also affects phage diffusion through the biofilm structure is
the presence of more than one microbial strain or species. It is estimated that most biofilm com-
munities found in nature are composed of a variety of microorganisms instead of a single one
(27). Testa et al. (28) demonstrated that the outcome of phage infection is influenced by both
the spatial structure of the biofilm and the presence of more than one strain. The interaction of
phages with multispecies biofilms is a rather complex process due to the higher diversity of poly-
meric substances and heterogeneity of the biofilm (14). Although these biofilms are expected to
be less susceptible to phage predation, more studies are needed to understand their interaction
with phages in real habitats.
2.2. How Phages Have Adapted to Infect Bacterial Biofilms
The long coevolution between phages and bacteria in nature has led them to evolve mecha-
nisms that facilitate their access to the bacterial cell surface, which might be particularly useful in
biofilms,where the bacterial cells are encased within the EPSmatrix. In fact, it is known that a large
number of phage genomes encode enzymes capable of degrading polymeric substances including
capsular polysaccharides, exopolysaccharides, or lipopolysaccharides (9, 29). These phage-derived
enzymes, called depolymerases, are mostly found as part of the tail fiber or tail spike proteins
of phages and are responsible for the depolymerization of bacterial capsules, facilitating phage
adsorption (29). Phage depolymerases may also play an important role in phage-host interac-
tion within biofilms by promoting matrix disruption and a consequent easier diffusion of phages
through the biofilm structure to the target bacterial cells (6).
In 1998,Hughes et al. (30) reported an Enterobacter agglomerans phage displaying depolymerase
activity that was capable of disrupting biofilms, a characteristic that was attributed to the combined
effect of EPS degradation caused by the enzyme and the subsequent cell lysis caused by the phage.
Similarly, studies by Cornelissen et al. (31) showed that although a Pseudomonas putida phage en-
coding a polysaccharide depolymerase revealed biofilm-degrading properties, phage amplification
had a major role in biofilm degradation, as the experiments using phage depolymerase alone did
not cause biofilm disruption. However, some studies have highlighted the role of depolymerases
in biofilm degradation and dispersion, even when these enzymes are applied alone. For instance,
Gutiérrez et al. (32) reported that an EPS depolymerase derived from a S. epidermidis phage was
able to prevent and disperse staphylococcal biofilms when applied alone, although the response
was dose dependent. In a similar way,Wu et al. (33) expressed a depolymerase encoded by a Kleb-
siella pneumoniae phage and applied it in mature biofilms, which revealed the biofilm-dispersion
ability of the enzyme.The antibiofilm properties of depolymerases may also be enhanced by other
phage-encoded enzymes, such as endolysins [lytic enzymes responsible for peptidoglycan degra-
dation and host cell lysis (34)], as described by Olsen et al. (35) in a study targeting Staphylococcus
aureus biofilms.
It is also important to highlight that phages can find other ways to penetrate the biofilm struc-
ture and reach the bacterial cells. In a study by Vilas Boas et al. (36), a fluorescence molecular
probe designed to target the messenger RNA of a phage major capsid was used to track phage-
infected cells within a biofilm population.The authors demonstrated that phage diffusion through
the biofilm may be mediated by the channels that can be found in some biofilms, as the phage-
infected cells were primarily located close to the edges of these structures (36).

























































































2.3. How Bacteria Evolved to Escape from Phage Predation
To date, several studies have reported the fast proliferation of bacteriophage-insensitive mutants
(BIMs) after biofilm treatment with phages (37–41). Although the mechanisms underlying phage
resistance in these studies are not always clear, the genotypic analysis of BIMs frequently reveals
mutations in genes encoding phage receptors (39, 41). Nonetheless, other mechanisms can be
used by bacteria to counterattack phage evasion, namely in biofilm mode, which include signaling
systems or CRISPR-Cas systems.
It is known that bacterial communication relies on signaling molecules, known as autoinducers,
which regulate gene expression in response to variations in population density by a process called
quorum sensing (QS) (42). Because QS plays an important role in controlling the gene expression
of virulence factors and biofilm development (43), this communication system is also relevant to
understand the phage-host dynamics in biofilm populations. In fact, QS can be extremely useful
when bacterial cells are under phage predation; consequently, it has been linked to increased phage
resistance in several ways (44, 45). One example is that QS signals can regulate the genes involved
in the production of biofilmmatrix (46, 47), which was described above as one of the major factors
impairing phage infection. Additionally, QS can modulate the expression of phage receptors in
bacterial cell surface as described by Høyland-Kroghsbo et al. (48). Using a model system of E. coli
and phage λ, the authors found that the bacterial host reduced the numbers of cell surface receptors
in response to QS signals, which resulted in a reduction in phage adsorption rate (48). Similar
observations concerning the QS regulation of antiphage mechanisms were also reported by Tan
et al. (49) in Vibrio anguillarum. In addition,QS can also influence phage infection by affecting the
physiological state of the host cell population, as observed for Pseudomonas aeruginosa (50). There
is also increasing evidence that QS can control the regulation of CRISPR-Cas systems of several
bacterial species, such as P. aeruginosa (51) or Serratia spp. (52). CRISPR-Cas systems are widely
distributed across bacterial genomes and provide them with adaptive immunity against invasive
genetic elements, including phages (53). Many other antiphage systems have been described over
the past few years (reviewed in 54, 55). These systems result from the long-term evolutionary
adaptation of bacteria to survive the constant offense of phages in natural environments. Overall,
QS contributes tomaintaining population stability when phage densities are relatively high.Other
density-dependent mechanisms, such as superinfection immunity, make important contributions
for the equilibrium of biofilm populations. This has been explained by the Piggyback-the-Winner
(PtW) theory, which proposes that the phenotypic advantages of lysogeny are favored at high host
abundances (56).
Because of all these defense mechanisms, and similar to what happens under lab conditions, the
presence of phage-resistant bacteria is also expected in biofilms found in natural contexts. How-
ever, it is not clear how these resistant populations will interact with phages in biofilms. To better
understand the dynamics of a phage-resistant population within biofilms, Simmons et al. (57) set
up an experimental model of mixed E. coli biofilms with resistant and susceptible hosts subjected to
T7 phage attack,whichwas analyzed by confocalmicroscopy.According to the authors, the biofilm
structure promotes the coexistence of both phage-resistant and phage-susceptible bacteria.When
phage-resistant cells are initially rare in the biofilm, the susceptible cells are cleared by phage and
the number of phage-resistant cells will increase and form clusters in the empty space; however,
when phage-resistant cells are initially common (at least 60% of the population), the relative frac-
tion of resistant and susceptible bacteria will not substantially change after phage treatment, as the
susceptible cells are protected from phage exposure through immobilization of phages in clusters
of resistant cells, resulting in a more structured biofilm composed of both populations (57).

























































































2.4. How Phages Can Modulate and Trigger Biofilm Formation
Although several studies have highlighted the potential of phages for biofilm control, not all
phages have this ability, and studies have shown evidence that some phages can modulate biofilm
formation and even increase biofilm levels (44). This can be explained by the selective pressure
caused by phages that results in fast propagation of phage-resistant cells or by the induction of
prophages that contributes to a release of biofilm-promoting molecules.
Hosseinidoust et al. (58) studied whether a phage treatment can lead to enhanced biofilm for-
mation in consequence of resistant cells or spatial refuges. To address this question, the authors
exposed single-species biofilms (P. aeruginosa, Salmonella enterica, and S. aureus) to specific phages
(as a pretreatment or post-treatment) and observed that some phage treatments resulted in in-
creased biofilm formation with levels above the control (58). In a study by Henriksen et al. (59),
where different phage treatments against P. aeruginosa flow-cell biofilms were evaluated, the au-
thors observed that repeated phage treatments (three phage doses every 24 h) did not improve the
antibiofilm efficacy of phages, resulting in a significant increase of microcolonies, which provide
protection from phages, as well as increased biofilm thickness. Tan et al. (60) studied the effect of
two vibriophages in the biofilm formation ofV. anguillarum and observed different effects depend-
ing on the phage used: While one of the phages was able to control biofilm formation, the other
one stimulated biofilm development. The authors of the study explained the different behaviors
of the phages by the presence of spatial refuges formed by some strains, which can promote the
coexistence of phages and bacteria, as already mentioned above. The authors also highlighted
the diversity of phage-host interactions even within the same bacterial species (60). Similarly,
Fernández et al. (61) showed that the exposure of S. aureus biofilms to subinhibitory doses of
phages can promote biofilm formation and protect cells from complete eradication.
Although these studies were performed with lytic phages, prophages are also known to directly
affect biofilm formation. In fact, prophage induction during biofilm development might mediate
a release of biofilm-promoting components as observed by Carrolo et al. (62). In this study, the
authors reported that the lysis of Streptococcus pneumoniae host cells mediated by spontaneous in-
duction of prophages into the lytic cycle contributed to extracellular DNA (eDNA) release, which
favored biofilm formation by the remaining pneumococcal population (62). This is not surpris-
ing because eDNA is a key component of the biofilm matrix of most bacterial species, and it is
known to have a major role in biofilm development by promoting adhesion to surfaces and main-
tenance of the structural integrity of biofilms (reviewed in 63). The enhanced biofilm formation
in consequence of phage-induced lysis was also reported by Gödeke et al. (64).While the cell lysis
mediated by three prophages harbored in the genome of Shewanella oneidensis MR-1 promoted
biofilm formation, a bacterial mutant devoid of prophages revealed impaired biofilm formation
ability (64). Similar observations related to the ability of prophages to trigger biofilm formation
were also reported for Actinomyces odontolycus (65). In addition to these studies, it is important to
highlight that the P. aeruginosa filamentous phages (Pf-like) have also been revealed to play an
important role in the life cycle and structural integrity of P. aeruginosa biofilms (66, 67). Another
interesting example of how phages can modulate biofilm formation was reported by Ojha et al. in
Mycobacterium (68). In this study, the authors observed that the integration of the Mycobacterium
smegmatis temperate phage Bxb1 led to the inactivation of gene groEL1, which contains the attB
site for phage integration. Although Bxb1 integration did not affect the planktonic growth of bac-
teria, it prevented biofilm maturation, as the groEL1 gene is involved in the synthesis of mycolic
acids, namely during biofilm formation.
Although some of the studies described above established a link between prophage induction
and biofilm formation, the cell lysis mediated by spontaneously induced prophages may also lead

























































































to biofilm dispersion. For instance, Rossmann et al. (69) demonstrated that high levels of the
QS molecule Al-2 produced by Enterococcus faecalis induced the dispersal of bacterial cells from
established biofilms due to prophage release. In a recent study by Tan et al. (70), the authors
also highlighted the role of QS signaling in coordinating phage-host interaction and biofilm
formation in V. anguillarum; however, in this study an H2O-like prophage stimulated the host’s
biofilm formation, although its induction was repressed byQS. In a study using P. aeruginosa PA14,
Zegans et al. (71) observed that lysogeny by phage DMS3 inhibited biofilm formation and swarm-
ing motility of the strain. According to the authors, this inhibition was explained by a concerted
action of the phage and the CRISPR system of the host (71).
3. METHODS OF STUDYING PHAGE-BIOFILM INTERACTION
Although numerous methods of biofilm formation have been described in the literature, there is
still a lack of standardized and appropriate protocols to simulate real biofilms under laboratory
conditions. The type of device used for biofilm formation, the culture media, and the presence of
external stresses (e.g., shear forces) will directly influence the biofilm structure, which will have a
major impact on the outcome of phage treatment. Below we present an overview of the experi-
mental setups that are most commonly used to form biofilms, as well as the different methods that
have been implemented to study phage-biofilm interactions (Figure 2).
3.1. Experimental Setups for Biofilm Formation
The choice of an adequate platform for biofilm experiments can determine the outcome results.
Numerous factors can influence biofilm formation, structure, and composition and consequently
impact phage interaction with biofilm cells.
3.1.1. In vitro models and the influence of biofilm formation conditions. The majority
of in vitro biofilm studies involve the use of microtiter plates as experimental setups (72). The
main advantages of using these devices are their low price and the possibility of performing high-
throughput studies (72). There are several studies reporting the efficacy of phages against biofilms
formed in microtiter plates, and a compilation of them was previously reviewed (6). However, it is
with high difficulty that the results obtained using different microtiter devices can be translated
to the reality found in different biofilms of environmental, clinical, food industry, or veterinary
contexts. The biofilms formed in real conditions face several stresses, namely shear forces under
continuous liquid flow that static devices cannot mimic. Therefore, for a better understanding of
phage-host interactions, the use of more sophisticated biofilm dynamic models is recommended.
Examples of dynamic devices are flow cells, drip flow reactors, modified Robbins devices, and
rotary biofilm devices (72). In a study by Rieu et al. (73), time-lapse CLSM was used to charac-
terize the structural dynamics of Listeria monocytogenes growth in static (stainless steel chips on
petri dishes) and dynamic (flow cell BST FC 81) conditions. In static conditions, thin unstruc-
tured biofilms were observed, while when biofilms were grown under dynamic conditions, they
were highly organized with microcolonies surrounded by a network of knitted chains (73). More
recently, Yang et al. (74) used nitrogen sparging to induce shear stress on biofilms formed on cubic
dual-chamber air-cathode microbial fuel cells with a cation exchange membrane. Using electro-
chemical impedance, the authors observed that a shear stress–enriched anode biofilm showed a
low-charge transfer resistance in comparison with the unperturbed enriched anode biofilm.More-
over, CLSM micrographs clearly indicated that the shear stress–enriched biofilms were entirely
viable, in opposition to unperturbed biofilms that exhibited a viable outer layer with a high propor-
tion of dead cells in the inner layers of the biofilm (74).Taken together, these results emphasize the
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Representation of the methods used for biofilm formation and studying phage-biofilm interactions. Abbreviations: AFM, atomic force
microscopy; CFU, colony-forming unit; CLSM, confocal laser scanning microscopy; qPCR, quantitative PCR. Figure adapted from
images created with BioRender.com.
importance of shear stress conditions on the biofilm formation outcome, which ultimately affects
interaction with phages.
Another important feature of biofilm studies is the effect of culture media on the biofilm struc-
ture and cells. Most biofilm studies are performed with bacteria growing in rich media. Jones
et al. (75) used CLSM to compare the structure of Proteus mirabilis biofilms formed in Luria–
Bertani broth and artificial urine. The authors observed that while biofilms formed on rich media
displayed the typical mushroom structure with water/nutrient channels, biofilms formed using
artificial urine exhibited a flat structure almost deprived of channels (75). Different phage-biofilm
interaction studies were assessed on dynamic biofilms using simulated body fluids. In a study us-
ing microtiter plates, a phage cocktail containing two enterococci phages successfully reduced the
bacterial load after three hours of infection in a medium simulating wound conditions (76). In two

























































































other studies (77, 78), phage cocktails were successfully applied on sections of Foley catheters to
reduce biofilms grown in artificial urine.
Both biofilm-formation devices and conditions used, such as culture media, highly interfere
with biofilm structure and composition. As previously discussed, this has a huge influence on the
way phages interact with biofilms.
3.1.2. Ex vivo and in vivo models. The majority of studies mimicking real conditions are usu-
ally performed to simulate phage therapy against infectious biofilms. Lebeaux et al. (79) discussed
the applicability of ex vivo models as an interesting alternative approach to the use of in vivo
models. Ex vivo models have reduced alterations of natural conditions, as they involve the use
of tissue derived from a living organism in an artificial environment. In comparison to in vivo
models, they also allow a more controlled experimental setup, with reduced ethical concerns. For
example, phages were applied in porcine skin to simulate wound treatment of infections caused by
different pathogens (80, 81). Despite the advantages of using this type of model, the lack of host
(human or animal) response and the short duration of experiments are still some hurdles to the
widespread implementation of ex vivo models. In that sense, in vivo models are the best choice for
studies that intend to understand the pathology of infection. Recently, a comprehensive review
of the most relevant in vivo studies accomplished in the past decade was published, and differ-
ent routes of phage administration, dosage effect, and different animal models of distinct types of
infections were compared (82). It is important to highlight that the in vivo studies performed in
biofilm models usually represent acute infections, in opposition to real biofilm infections that are
usually characterized by their chronicity and recalcitrance (83).
3.2. Methods of Studying Phage-Biofilm Interactions
Phage-biofilm interactions can be studied by a set of approaches that assess biofilm biomass and/or
cell viability. These approaches can be divided into culture-based, molecular, physical, chemical,
microscopy, and computational and mathematical models (Figure 2). The advantages and disad-
vantages of the majority of these methods have been thoroughly reviewed (72).
3.2.1. Culture-based methods. The determination of the number of colony-forming units
(CFUs) is the most widely used technique to assess the efficacy of phage killing in biofilms. This
technique is based on serial dilutions of bacterial suspensions; it is a straightforward and univer-
sally used method. But despite these advantages, CFU determination usually underestimates the
number of biofilm cells. Biofilms are composed of a subpopulation of viable but nonculturable
cells that normally are not detected by CFUs (84). In addition, the presence of biofilm aggregates
also dramatically interferes with cell counting (85).
3.2.2. Molecular methods. In an alternative to culture-based methods, PCR- or molecular-
based methods can be used to study biofilm communities. These approaches allow the quantifi-
cation of the number of viable cells, usually assessed by quantitative (q) PCR. Unlike CFU de-
termination, regular qPCR frequently overestimates the number of viable cells, as the results are
influenced by the presence of eDNA and dead cells (86). To overcome this limitation,Magin et al.
(87) used PEMAX® dye, which detects only metabolically active cells, to study the effect of phages
against P. aeruginosa biofilms.
Whole-transcriptome analysis has also been used to study the effect of phages on biofilm cells.
Fernández et al. (61) showed that when S. aureus biofilms were exposed to low doses of phage
vB_SauM_phiIPLA-RODI (phiIPLA-RODI), the cells entered a unique physiological state that

























































































can benefit both prey and predator. This happens because, under phage predation, biofilms are
thicker and have higher amounts of eDNA. In addition, RNA sequencing data evidenced that
infected biofilms activate a stringent response that can delay phage infection progression, helping
both populations tend to an equilibrium (61).
3.2.3. Physical methods. The aforementioned limitation on biofilm cell counting accuracy can
be overcome by using flow cytometry in combination with bacterial cell staining with viability flu-
orophores (88). In addition to a very quick and precise cell counting, using an appropriate dye,
this methodology also allows an evaluation of the physiological state of cells (88). This methodol-
ogy has been suggested as a very promising approach to study, in almost real time, phage-biofilm
interactions (89).
Other physical methods can be used to assess biofilm biomass, such as wet or dry weight mea-
surements. Sillankorva et al. (90) used the dry weight method to calculate the amount of biofilm
biomass reduction caused by a Pseudomonas fluorescens phage when interacting with biofilms of
different stages of maturity.
In the past decade, a more sensitive method based on electrical impedance has also been applied
to study the effect of phages against biofilms. This methodology allows a real-time analysis of
different electric parameters that can be used to assess phage efficacy against biofilms (91) or to
measure physiological modifications of matrix composition after phage challenge (92).
3.2.4. Chemical methods. Chemical methods allow indirect measurement of biofilm compo-
nents, through the use of dyes or fluorochromes that can adsorb or bind to cells or matrix compo-
nents, or assessment of the cellular physiology of biofilms. For example, resazurin (93) and XTT
[2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt] (94) have
been used to determine the effect of phages against biofilms. Despite the widespread use of these
methods, there is a lack of reproducibility associated with them. In addition, the fact that a standard
protocol is not available makes the comparison of results among different studies difficult.
3.2.5. Microscopy methods. Numerous microscopy-based imaging modalities are available to
analyze biofilms; their pros and cons have been widely discussed elsewhere (72). Several of these
approaches have already been used to examine phage-biofilm interactions, namely epifluorescence
microscopy, CLSM (95), scanning electron microscopy (SEM) (96), field emission SEM (90), and
atomic force microscopy (97). An optical system that allows simultaneous imaging of individual
bacterial cells over a 36-mm2 field of view was recently developed (98). With this system, E. coli
biofilms were observed in a detail never seen before, and new intracolony channels with an ap-
proximately 10-µm diameter were discovered (98).
For fluorescence microscopy, biofilm elements need to be marked with fluorescence probes.
Microbial cells are usually stained with DAPI or LIVE/DEAD for viability. Components of the
biofilm matrix can be marked with fluorescence-labeled lectins such as wheat germ agglutinin
conjugated with different fluorophores. Recently, different fluorescence-based approaches were
designed to study phage-biofilm interactions. For instance, Akturk et al. (99) designed bacteria-
specific fluorescent probes based on phage proteins to discriminate between S. aureus and P. aerug-
inosa on dual-species biofilms. Another elegant approach is based on the use of fluorescence in
situ hybridization (FISH). Although phageFISH was designed to detect Pseudoalteromonas using
polynucleotide probes (100), more recent techniques using locked nucleic acid probes as an alter-
native to DNA probes proved to be very successful when applied on biofilms. These probes allow
the discrimination of phage-infected cells and the visualization of their spatial distribution within
single-species (20) or multi-species biofilms (36).

























































































3.2.6. Computational and mathematical models. Mathematical models hold great potential
for the quantitative description of the population dynamics in a biofilm following phage predation.
For example, Heilmann et al. (101) used stochastic spatial models to study the degree of bacterial
susceptibility to phage predation. The authors showed that bacterial density or biofilm forma-
tion can produce refuges and edges in a self-organized manner (101). Laboratory experiments
performed by Li et al. (102) demonstrated that, when phages find motile hosts, a well-delimited
lysis zone is formed; when the authors applied a mathematical model, they observed that the ly-
sis pattern was a consequence of local nutrient depletions and inhibition of bacterial and phage
motility. In a similar approach, Ping et al. (103) showed that phage mobility requires virus particles
to hitchhike with moving bacteria, which can simulate what happens on biofilms.
A mathematical model developed by Eriksen et al. (104) predicted that biofilm microcolonies
formed only by phage-sensitive bacteria have the ability to survive due to the bacterial growth
throughout the microcolony, which can exceed the rate at which the cells are being killed by
phage action. Using mathematical models and a computational framework, Simmons et al. (105)
developed simulations that led to the conclusion that the equilibrium state of interaction between
phages and biofilms is largely affected by the nutrient availability of biofilm cells, the infection
likelihood per encounter, and the capacity of phages to diffuse through the biofilms. The authors
also concluded that the biofilm matrix has a role in controlling these interactions by governing
the extent to which prey and predator can coexist in the environment (105). In another study, a
computer simulation of phage-host dynamics during biofilm development was applied based on
experimental data obtained using S. aureus and the virulent phage phiIPLA-RODI (106). The re-
sults demonstrated that even small differences on pH evolution can dramatically affect the course
of biofilm infection, suggesting that phage-host interactions can be tightly coordinated by differ-
ent environmental signals (106). Very recently, Hartmann et al. (107) developed BiofilmQ, which
is an innovative image cytometry software tool that allows automated and high-throughput quan-
tification, analysis, and visualization of numerous biofilm properties. This tool is able to provide
quantitative data from data analysis by scientists without programming skills to study biofilms and
will provide new insights into phage-biofilm interaction.
4. APPLICATIONS OF PHAGES FOR BIOFILM CONTROL
Phages can access and kill sessile bacteria causing biofilm destruction through mechanisms that
were already discussed. This feature has boosted the development of several phage-based strate-
gies to control biofilms in a variety of anthropogenic contexts where biofilms are harmful. The
use of phages to combat biofilm-associated infections is usually referred to as phage therapy,
while the application of phages to control environmentally detrimental biofilms is considered
phage biocontrol.
In this section we present the latest developments related to the application of phages as thera-
peutics and biocontrol agents, and we discuss the challenges and pathways for future developments
(Figure 3).
4.1. Phages to Control Clinically Relevant Biofilms
Biofilms are associated with a variety of chronic and difficult-to-treat infections. They can be
formed on human tissues, causing tissue-related infections (e.g., endocarditis, lung infections,
periodontitis, rhinosinusitis, osteomyelitis, chronic wounds, meningitis, and kidney infections),
and on indwelling materials, triggering device-related infections (108). The serious implications
of biofilms on human health and the renewed interest in phage therapy have motivated the




















































































































Schematic representation of the different applications of phages against biofilms. Figure adapted from
images created with BioRender.com.
investigation of phage-biofilm interactions toward the development of phage therapy against
infectious biofilms. Phages have also been proposed as antimicrobial coatings or sanitizing agents
to prevent and control device-associated infections.
4.1.1. Phage therapy against infectious biofilms. While many studies have addressed phage
therapy against infectious biofilms in vitro and in vivo, the number of case reports and clinical
trials is still scarce. Despite the already-mentioned limitations of using in vitro studies, they have
been important to describe the dynamic of phage-biofilm interaction and to identify the features
that can contribute to impair the efficacy of phages against biofilms.
One of the main limitations of phage therapy is the rapid emergence and proliferation of BIMs.
Pires et al. (41) reported P. aeruginosa biofilm regrowth 6 h after application of a single phage
treatment in vitro, which was attributed to the proliferation of BIMs lacking phage receptors.
The same has been reported for phage-treated biofilms of K. pneumoniae, where a rapid regrowth
was observed following the initial lysis, suggesting that phage-resistant variants were selected in
the host populations (109).
The clinical significance of BIMs remains unclear. Several studies have shown that phage resis-
tance may diminish fitness or virulence of these bacterial variants and therefore facilitate clearance
by the immune system (110). Olszak et al. (111) demonstrated that a P. aeruginosa biofilm popula-
tion that survived PA5oct jumbo phage treatment became sensitive to the immune system due to
the reduced virulence of BIMs. Despite the fact that resistance can be associated with decreased
bacterial virulence, phage resistance should not be underestimated and efforts should be made to
develop methodologies for preventing it.

























































































The application of cocktails composed of phages that target different cell receptors has been
suggested to improve phage therapy by extending host range and reducing resistance (112).This is
particularly important in biofilms, in which the application of cocktails rather than a single phage
can delay (41) or even prevent the emergence of bacteria-resistant variants. Morris et al. (113)
evaluated the therapeutic effect of a phage cocktail for treating peri-prosthetic joint infections
caused by S. aureus in rats and demonstrated that the bacterial isolates recovered from the infected
knee of the animals that received phage therapy remained susceptible to the five-phage cocktail.
Another way to prevent phage resistance is combining phages with antibiotics. Verma et al.
(114) prevented the emergence of phage-resistant variants during treatment of K. pneumoniae
biofilms by combining ciprofloxacin with phages. The application of phages with antibiotics, si-
multaneously or sequentially, has been described as particularly effective against biofilms. Syner-
gism may occur because phage-associated bacterial lysis releases nutrients that can reactivate the
metabolic activity of the growth-arrested cells,which become sensitive to antibiotics.Cell lysis also
causes a dispersion of the EPS, enhancing the diffusion of the antibiotic to the inner matrix layers,
whereas the oxygen availability increases the drug activity (108). In some cases, phage-resistant
cells might be more susceptible to antibiotics (115).
Besides resistance, the efficacy of phage therapy against biofilms can be compromised by the
deficient phage penetration into the biofilmmatrix, as already mentioned.Nevertheless,mechani-
cal or enzymatic disruption of the biofilm can facilitate phage infection, which was already proven
both in vitro and in vivo. Melo et al. (20) reported poor antibiofilm activity by a sepunavirus,
despite its high activity against planktonic cells at different growth stages. It is noteworthy that
the authors demonstrated that after mechanical disturbance, the biofilm becomes susceptible to
phage attack. In a study by Seth et al. (116), the application of a phage treatment in S. aureus
biofilm wounds had no effect on healing; however, when the phage was administered after sharp
debridement, wound healing parameters assessed by histological analysis improved significantly
and bacterial counts were reduced.
In clinical contexts, mechanical debridement has also been applied as a routine care procedure
before phage application. Patey et al. (117) summarized the outcomes of 15 compassionate phage
therapy treatments (from 2006 to 2018) in patients suffering from osteoarticular infections caused
predominantly by S. aureus monospecies biofilms and, more rarely, polymicrobial infections with
the presence of P. aeruginosa and E. coli. The results of the treatments were very satisfactory, with
12 of 15 patients completely recovered. The therapeutic procedure consisted of a prior debride-
ment and cleaning of the infectious foci, followed by the application of the phage preparation
(117).
4.1.2. Phages to control biofilms in medical devices. Biofilm formation in medical devices
(e.g., catheters, cardiac pacemakers, implants, contact lenses, endotracheal tubes, and others) is a
common cause of serious infections, which are responsible for a high number of deaths in health
care settings (118). In this context, phages may play an important role in preventing or even con-
trolling device-related infections in clinical environments.
Because one of the major challenges in health care settings is prevention of catheter-associated
infections, Curtin & Donlan (119) used an in vitro system to study the efficacy of phages as a
pretreatment of hydrogel-coated silicon catheters to prevent S. epidermidis biofilms. The authors
observed a significant reduction of biofilm formation in phage-treated catheters, suggesting that
this may be a promising approach to prevent device-associated infections. Using a similar in
vitro model, Fu et al. (38) developed a phage cocktail to prevent P. aeruginosa biofilm formation.
Although the phage pretreatment significantly reduced biofilm formation on catheters, phage-
resistant variants were isolated during the experiment. The potential of phages to prevent or

























































































control biofilms in catheters has also been widely studied against P. mirabilis, the leading cause of
catheter-associated urinary tract infections, and promising results were reported in these studies
(77, 78, 120).
Another interesting application is the use of phages for biofilm prevention or control in bioma-
terial surfaces. In a recent study, Bouchart et al. (121) assessed whether the Remus phage loaded on
a calcium phosphate–based ceramic device was able to prevent biofilm colonization. The authors
reported that the phage was able to not only prevent S. aureus biofilm initiation but also destroy
established biofilms formed onmicrotiter plates. In addition, they observed that Remus phage was
safe for osteoblastic cell proliferation, leading them to conclude that the phage-loaded material
could be a good strategy to prevent bacterial infections in bone and joint surgery (121).
4.2. Phages to Control Industrially Relevant Biofilms
The formation of biofilms in industrial settings represents a great challenge for industries, par-
ticularly the food industry. Biofilms tend to accumulate on surfaces in industrial settings, caus-
ing corrosion, loss of efficiency of certain equipment (e.g., heat exchangers), and contamination
of food products. Chemical disinfection usually fails to efficiently sanitize food-contact surfaces
where biofilms have accumulated, due to the high tolerance of biofilms to disinfection.
4.2.1. Phages to control foodborne biofilms. Phage biocontrol is increasingly accepted as
a natural and green technology for targeting bacterial pathogens in various foods and food-
contact surfaces (122).Many phage preparations (e.g.,ListShieldTM,ListexTM P100,EcoShieldTM,
SalmoFreshTM, FinalyseTM) have been granted Generally Recognized as Safe designation by the
Food and Drug Administration to be used as food additives and/or food-processing agents against
many foodborne pathogens. These products have been tested on contaminated foods but not
specifically on biofilms; nevertheless, it is most likely that they also have antibiofilm properties.
It is noteworthy that Listex P100 and ListShield have been assessed for L. monocytogenes biofilm
removal on different food-contact surfaces and lettuce, and promising results were reported (123–
126). Biofilms formed by Salmonella, another important foodborne pathogen, have also been the
subject of many phage biocontrol studies. For example, a cocktail of two phages proved to be very
effective in removing Salmonella spp. biofilms from stainless steel, rubber, and lettuce surfaces
(127). Another interesting example is the control of dual-species biofilms formed by Salmonella
and E. coli (128). Milho et al. (128) observed that the biofilms formed by the two species were less
susceptible to phage predation than the monospecies ones, raising awareness of the difficulty of
controlling multispecies biofilms on industrial surfaces. González et al. (129) also characterized
the interaction of an S. aureus phage with dual-species biofilms formed by combining the S. aureus
host with different bacterial species. The results suggested that the effect of phage treatment on
S. aureus mixed biofilms varies depending on the accompanying species and the infection condi-
tions (129). These results highlight the need to study the effect of phage biocontrol on microbial
communities that reflect more realistic conditions.
Phages did not always exhibit good killing properties against foodborne biofilms. Many stud-
ies have reported moderate to low killing efficacies that are not sufficient for an efficient surface
sanitation. This is the case with a cocktail of three phages that failed to destroy established Vibrio
parahaemolyticus biofilms (130). Nevertheless, the phages demonstrated a great ability to prevent
biofilm formation (130). This feature is extensively reported in many phage-biofilm studies. Even
if the phage is not able to reduce the cell population of a mature biofilm, it can prevent the biofilm
from further proliferation (131). For example, Endersen et al. (132) demonstrated the success-
ful use of a phage cocktail targeting Citrobacter sakazakii, an important pathogen involved in the
contamination of infant formula, to prevent biofilm formation.

























































































Several strategies have been suggested to improve phage efficacy against foodborne biofilms.
As described previously for clinical purposes, the use of a cocktail of phages against foodborne
biofilms is also highly recommended to limit the emergence of BIMs. Other strategies are based
on the combination of phages with other sanitizing agents (that do not inactivate phages) (133,
134) or essential oils (135). An interesting work by Li et al. (136) demonstrated the potential of
using phages attached to magnetic colloidal nanoparticle clusters that facilitate biofilm penetra-
tion under a relatively small magnetic field, which led to approximately 90% biofilm removal of
P. aeruginosa and E. coli biofilms within 6 h of treatment.
4.2.2. Water transport and treatment systems. Water systems are among the industrial de-
vices most affected by biofilms. Pipes and water-cooling systems are usually colonized by biofilms
that can induce corrosion and equipment damage.Most importantly, the biofilms formed in these
systems are often a reservoir for pathogenic bacteria (V. cholerae,Helicobacter pylori, Legionella spp.)
(137–139). Phages are very specific and therefore cannot match the broad-spectrum capabilities
of antimicrobial chemicals used in water disinfection, but they can be used to specifically target
dangerous or problematic bacteria present in water transport and treatment systems. For example,
Naser et al. (140) tested the effect of three vibriophages against V. cholerae biofilms and concluded
that one of the phages could degrade the biofilmmatrix ofV. cholerae and increase the concentration
of planktonic V. cholerae in water, whereas the other two phages could effectively kill planktonic
V. cholerae cells, suggesting that a possible combination of diverse phages can be effective in con-
trolling waterborne pathogens.Other possible applications of phages in water treatment processes
were discussed by Mathieu et al. (141).
Another industrial application of phages is in water treatment plants as a means to control
antibiotic-resistant bacteria (ARB), as proposed by Yu et al. (142). In this study, the authors used
a cocktail of polyvalent E. coli phages to suppress the proliferation of ARB in activated sludge
microcosms, and they observed that the phages were able to reach high densities and significantly
decrease ARB.
The impact of the extensive application of phages in the environment is still controversial
due to the question of if this could lead to widespread phage-resistant bacteria, compromising the
future of phage therapy.There is no definitive answer; however, as phages are naturally coevolving
with bacteria, it seems improbable that the arms race between phages and their bacterial hosts will
come to an end.
5. SUMMARY AND FUTURE PROSPECTS
Phage efficacy in controlling biofilms formed either in industrial settings or on human and animal
surfaces is limited by the intrinsic biological properties of phages and the protective shield of the
biofilm. Phages are unquestionably powerful weapons to combat undesirable biofilms, but they
have limitations. It is important to understand the factors that hamper phage efficacy in order to
design effective phage-based biocontrol strategies. The many strategies that have been suggested
are already discussed in other reviews and mostly rely on combining phages with chemical, en-
zymatic, or physical treatments or rely on the use of genetically engineered phages. Regardless
of the strategy used to coadjuvate phages, it is important to remember that biofilms are dynamic
structures that vary in composition and structure in response to environmental conditions and
that phages respond differently to different biofilms. Therefore, the complexity and diversity of
phage-biofilm interactions limit broad conclusions and call for more research in this area. Partic-
ularly, there is a need to establish standardized methods for assessing phage-biofilm interactions
in different contexts of application, which will allow for rigorous testing of phages for either ther-
apeutic purposes or biocontrol against biofilms.
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23. Łoś M, Golec P, Łoś JM, Weglewska-Jurkiewicz A, Czyz A, et al. 2007. Effective inhibition of lytic
development of bacteriophages λ, P1 and T4 by starvation of their host, Escherichia coli. BMC Biotechnol.
7:13
24. Bryan D, El-Shibiny A, Hobbs Z, Porter J, Kutter EM. 2016. Bacteriophage T4 infection of stationary
phase E. coli: life after log from a phage perspective. Front. Microbiol. 7:1391
25. Melo LDR, França A, Brandão A, Sillankorva S, Cerca N, Azeredo J. 2018. Assessment of Sep1virus
interaction with stationary cultures by transcriptional and flow cytometry studies. FEMSMicrobiol. Ecol.
94(10):fiy143
26. Tkhilaishvili T, Lombardi L, Klatt AB, Trampuz A, Di Luca M. 2018. Bacteriophage Sb-1 enhances an-
tibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus
aureus. Int. J. Antimicrob. Agents 52(6):842–53
27. Elias S, Banin E. 2012. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol. Rev.
36(5):990–1004
28. Testa S, Berger S, Piccardi P, Oechslin F, Resch G,Mitri S. 2019. Spatial structure affects phage efficacy
in infecting dual-strain biofilms of Pseudomonas aeruginosa. Commun. Biol. 2(1):405
29. Knecht LE, Veljkovic M, Fieseler L. 2020. Diversity and function of phage encoded depolymerases.
Front. Microbiol. 10:2949
30. Hughes KA, Sutherland IW, Jones MV. 1998. Biofilm susceptibility to bacteriophage attack: the role of
phage-borne polysaccharide depolymerase.Microbiology 144:3039–47
31. Cornelissen A, Ceyssens P-J, Krylov VN, Noben J-P, Volckaert G, Lavigne R. 2012. Identification
of EPS-degrading activity within the tail spikes of the novel Pseudomonas putida phage AF. Virology
434(2):251–56
32. Gutiérrez D, Briers Y, Rodríguez-Rubio L, Martínez B, Rodríguez A, et al. 2015. Role of the pre-neck
appendage protein (Dpo7) from phage vB_SepiS-phiIPLA7 as an anti-biofilm agent in staphylococcal
species. Front. Microbiol. 6:1315
33. Wu Y, Wang R, Xu M, Liu Y, Zhu X, et al. 2019. A novel polysaccharide depolymerase encoded by
the phage SH-KP152226 confers specific activity against multidrug-resistant Klebsiella pneumoniae via
biofilm degradation. Front. Microbiol. 10:2768
34. Schmelcher M, Donovan DM, Loessner MJ. 2012. Bacteriophage endolysins as novel antimicrobials.
Future Microbiol. 7(10):1147–71
35. Olsen NMC, Thiran E, Hasler T, Vanzieleghem T, Belibasakis GN, et al. 2018. Synergistic removal of
static and dynamic Staphylococcus aureus biofilms by combined treatment with a bacteriophage endolysin
and a polysaccharide depolymerase. Viruses 10(8):438
36. Vilas Boas D, Almeida C, Sillankorva S, Nicolau A, Azeredo J, Azevedo NF. 2016. Discrimination of
bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH).
Biofouling 32(2):179–90
37. Lacqua A, Wanner O, Colangelo T, Martinotti MG, Landini P. 2006. Emergence of biofilm-forming
subpopulations upon exposure of Escherichia coli to environmental bacteriophages. Appl. Environ.
Microbiol. 72:956–59
38. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. 2010. Bacteriophage cocktail for the
prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.
Antimicrob. Agents Chemother. 54(1):397–404
39. Le S, Yao X, Lu S, Tan Y, Rao X, et al. 2014. Chromosomal DNA deletion confers phage resistance to
Pseudomonas aeruginosa. Sci. Rep. 4:4738
40. Hosseinidoust Z, Tufenkji N, van de Ven TGM. 2013. Predation in homogeneous and heterogeneous
phage environments affects virulence determinants of Pseudomonas aeruginosa. Appl. Environ. Microbiol.
79:2862–71

























































































41. Pires DP, Dötsch A, Anderson EM, Hao Y, Khursigara CM, et al. 2017. A genotypic analysis of five
P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors. Front.
Microbiol. 8:1229
42. Miller MB, Bassler BL. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165–99
43. NgW-L, Bassler BL. 2009. Bacterial quorum-sensing network architectures. Annu. Rev. Genet. 43:197–
222
44. Fernández L, Rodríguez A, García P. 2018. Phage or foe: an insight into the impact of viral predation
on microbial communities. ISME J. 12(5):1171–79
45. Moreau P, Diggle SP, Friman VP. 2017. Bacterial cell-to-cell signaling promotes the evolution of resis-
tance to parasitic bacteriophages. Ecol. Evol. 7(6):1936–41
46. Sakuragi Y, Kolter R. 2007. Quorum-sensing regulation of the biofilm matrix genes (pel) of Pseudomonas
aeruginosa. J. Bacteriol. 189(14):5383–86
47. Parsek MR, Greenberg EP. 2005. Sociomicrobiology: the connections between quorum sensing and
biofilms. Trends Microbiol. 13:27–33
48. Høyland-Kroghsbo NM,Maerkedahl RB, Svenningsen SL. 2013. A quorum-sensing-induced bacterio-
phage defense mechanism.mBio 4(1):e00362-12
49. Tan D, Svenningsen SL, Middelboe M. 2015. Quorum sensing determines the choice of antiphage de-
fense strategy in Vibrio anguillarum.mBio 6(3):e00627-15
50. Qin X, SunQ,Yang B,Pan X,He Y,YangH. 2017.Quorum sensing influences phage infection efficiency
via affecting cell population and physiological state. J. Basic Microbiol. 57(2):162–70
51. Høyland-Kroghsbo NM, Paczkowski J,Mukherjee S, Broniewski J,Westra E, et al. 2017.Quorum sens-
ing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system. PNAS 114(1):131–35
52. Patterson AG, Jackson SA, Taylor C, Evans GB, Salmond GPC, et al. 2016. Quorum sensing controls
adaptive immunity through the regulation of multiple CRISPR-Cas systems.Mol. Cell 64(6):1102–8
53. Deveau H, Garneau JE, Moineau S. 2010. CRISPR/Cas system and its role in phage-bacteria interac-
tions. Annu. Rev. Microbiol. 64:475–93
54. Seed KD. 2015. Battling phages: how bacteria defend against viral attack. PLOS Pathog. 11(6):e1004847
55. Rostøl JT, Marraffini L. 2019. (Ph)ighting phages: how bacteria resist their parasites. Cell Host Microbe
25(2):184–94
56. Knowles B, Silveira CB, Bailey BA, Barott K, Cantu VA, et al. 2016. Lytic to temperate switching of viral
communities.Nature 531(7595):466–70
57. Simmons EL,BondMC,Koskella B,Drescher K,Bucci V,Nadell CD. 2020. Biofilm structure promotes
coexistence of phage-resistant and phage-susceptible bacteria.mSystems 5(3):e00877-19
58. Hosseinidoust Z, Tufenkji N, van de Ven TGM. 2013. Formation of biofilms under phage predation:
considerations concerning a biofilm increase. Biofouling 29(4):457–68
59. Henriksen K, Rørbo N, Rybtke ML, Martinet MG, Tolker-Nielsen T, et al. 2019. P. aeruginosa flow-
cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage–ciprofloxacin
combination: monitoring the phage–P. aeruginosa biofilms interactions. Pathog. Dis. 77(2):ftz011
60. Tan D, Dahl A, Middelboe M. 2015. Vibriophages differentially influence biofilm formation by Vibrio
anguillarum strains. Appl. Environ. Microbiol. 81(13):4489–97
61. Fernández L, González S, Campelo AB, Martínez B, Rodríguez A, García P. 2017. Low-level preda-
tion by lytic phage phiIPLA-RODI promotes biofilm formation and triggers the stringent response in
Staphylococcus aureus. Sci. Rep. 7:40965
62. Carrolo M, Frias MJ, Pinto FR, Melo-Cristino J, Ramirez M. 2010. Prophage spontaneous acti-
vation promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae. PLOS ONE
5(12):e15678
63. Okshevsky M, Meyer RL. 2015. The role of extracellular DNA in the establishment, maintenance and
perpetuation of bacterial biofilms. Crit. Rev. Microbiol. 41(3):341–52
64. Gödeke J, Paul K, Lassak J, Thormann KM. 2011. Phage-induced lysis enhances biofilm formation in
Shewanella oneidensisMR-1. ISME J. 5(4):613–26
65. Shen M, Yang Y, Shen W, Cen L,McLean JS, et al. 2018. A linear plasmid-like prophage of Actinomyces
odontolyticus promotes biofilm assembly. Appl. Environ. Microbiol. 84(17):e01263-18

























































































66. Rice SA, Tan CH, Mikkelsen PJ, Kung V, Woo J, et al. 2009. The biofilm life cycle and virulence of
Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J. 3:271–82
67. Secor PR, Sweere JM, Michaels LA, Malkovskiy AV, Lazzareschi D, et al. 2015. Filamentous bacterio-
phage promote biofilm assembly and function. Cell Host Microbe 18(5):549–59
68. Ojha A, AnandM, Bhatt A, Kremer L, JacobsWR Jr., Hatfull GF. 2005.GroEL1: a dedicated chaperone
involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123(5):861–73
69. Rossmann FS, Racek T, Wobser D, Puchalka J, Rabener EM, et al. 2015. Phage-mediated dispersal
of biofilm and distribution of bacterial virulence genes is induced by quorum sensing. PLOS Pathog.
11:e1004653
70. Tan D, Hansen MF, de Carvalho LN, Røder HL, Burmølle M, et al. 2020. High cell densities favor
lysogeny: induction of anH20 prophage is repressed by quorum sensing and enhances biofilm formation
in Vibrio anguillarum. ISME J. 14(7):1731–42
71. Zegans ME, Wagner JC, Cady KC, Murphy DM, Hammond JH, O’Toole GA. 2009. Interaction be-
tween bacteriophageDMS3 and hostCRISPR region inhibits group behaviors ofPseudomonas aeruginosa.
J. Bacteriol. 91(1):210–19
72. Azeredo J, AzevedoNF, Briandet R,Cerca N,Coenye T, et al. 2017.Critical review on biofilmmethods.
Crit. Rev. Microbiol. 43(3):313–51
73. Rieu A, Briandet R, Habimana O, Garmyn D, Guzzo J, Piveteau P. 2008. Listeria monocytogenes EGD-e
biofilms: no mushrooms but a network of knitted chains. Appl. Environ. Microbiol. 74(14):4491–97
74. Yang J, Cheng S, Li C, Sun Y, Huang H. 2019. Shear stress affects biofilm structure and consequently
current generation of bioanode in microbial electrochemical systems (MESs). Front. Microbiol. 10:398
75. Jones SM, Yerly J, Hu Y, Ceri H, Martinuzzi R. 2007. Structure of Proteus mirabilis biofilms grown in
artificial urine and standard laboratory media. FEMS Microbiol. Lett. 268(1):16–21
76. Melo LDR, Ferreira R, Costa AR, Oliveira H, Azeredo J. 2019. Efficacy and safety assessment of two
enterococci phages in an in vitro biofilm wound model. Sci. Rep. 9(1):6643
77. Lehman SM, Donlan RM. 2015. Bacteriophage-mediated control of a two-species biofilm formed by
microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.
Antimicrob. Agents Chemother. 59(2):1127–37
78. Melo LDR, Veiga P, Cerca N, Kropinski AM, Almeida C, et al. 2016. Development of a phage cocktail
to control Proteus mirabilis catheter-associated urinary tract infections. Front. Microbiol. 7:1024
79. Lebeaux D, Chauhan A, Rendueles O, Beloin C. 2013. From in vitro to in vivo models of bacterial
biofilm-related infections. Pathogens 2(2):288–356
80. Alves DR, Booth SP, Scavone P, Schellenberger P, Salvage J, et al. 2018. Development of a high-
throughput ex-vivo burn woundmodel using porcine skin, and its application to evaluate new approaches
to control wound infection. Front. Cell. Infect. Microbiol. 8:196
81. Milho C, Andrade M, Vilas Boas D, Alves D, Sillankorva S. 2019. Antimicrobial assessment of phage
therapy using a porcine model of biofilm infection. Int. J. Pharm. 557:112–23
82. Melo LDR, Oliveira H, Pires DP, Dabrowska K, Azeredo J. 2020. Phage therapy efficacy: a review of
the last 10 years of preclinical studies. Crit. Rev. Microbiol. 46:78–99
83. Bjarnsholt T. 2013. The role of bacterial biofilms in chronic infections. APMIS 121(s136):1–51
84. Ayrapetyan M, Williams T, Oliver JD. 2018. Relationship between the viable but nonculturable state
and antibiotic persister cells. J. Bacteriol. 200(20):e00249-18
85. Freitas AI, Vasconcelos C, Vilanova M, Cerca N. 2014. Optimization of an automatic counting system
for the quantification of Staphylococcus epidermidis cells in biofilms. J. Basic Microbiol. 54(7):750–57
86. Klein MI, Scott-Anne KM, Gregoire S, Rosalen PL, Koo H. 2012. Molecular approaches for viable
bacterial population and transcriptional analyses in a rodent model of dental caries.Mol. Oral Microbiol.
27(5):350–61
87. Magin V, Garrec N, Andrés Y. 2019. Selection of bacteriophages to control in vitro 24 h old biofilm of
Pseudomonas aeruginosa isolated from drinking and thermal water. Viruses 11(8):749
88. Cerca F, Trigo G, Correia A, Cerca N, Azeredo J, Vilanova M. 2011. SYBR green as a fluorescent probe
to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can. J.
Microbiol. 57(10):850–56

























































































89. Pires DP, Melo LDR. 2018. In vitro activity of bacteriophages against planktonic and biofilm popula-
tions assessed by flow cytometry. In Bacteriophage Therapy, ed. J Azeredo, S Sillankorva, pp. 33–41. New
York: Humana
90. Sillankorva S, Neubauer P, Azeredo J. 2008. Pseudomonas fluorescens biofilms subjected to phage phiIBB-
PF7A. BMC Biotechnol. 8:79
91. Gutiérrez D,Hidalgo-Cantabrana C, Rodríguez A,García P, Ruas-Madiedo P. 2016.Monitoring in real
time the formation and removal of biofilms from clinical related pathogens using an impedance-based
technology. PLOS ONE 11(10):e0163966
92. Guła G, Szymanowska P, Piasecki T, Góras S, Gotszalk T, Drulis-Kawa Z. 2020. The application of
impedance spectroscopy for Pseudomonas biofilm monitoring during phage infection. Viruses 12(4):407
93. Al-Zubidi M, Widziolek M, Court EK, Gains AF, Smith RE, et al. 2019. Identification of novel bacte-
riophages with therapeutic potential that target Enterococcus faecalis. Infect. Immun. 87(11):e00512-19
94. Lewis R, Clooney AG, Stockdale SR, Buttimer C, Draper LA, et al. 2020. Isolation of a novel jumbo
bacteriophage effective against Klebsiella aerogenes. Front. Med. 7:67
95. Vidakovic L, Singh PK, Hartmann R, Nadell CD, Drescher K. 2017. Dynamic biofilm architecture
confers individual and collective mechanisms of viral protection.Nat. Microbiol. 3(1):26–31
96. Tkhilaishvili T, Wang L, Perka C, Trampuz A, Gonzalez Moreno M. 2020. Using bacteriophages as
a Trojan horse to the killing of dual-species biofilm formed by Pseudomonas aeruginosa and methicillin
resistant Staphylococcus aureus. Front. Microbiol. 11:695
97. Dubrovin EV,Popova AV,Kraevskiy SV, Ignatov SG, IgnatyukTE, et al. 2012.Atomic forcemicroscopy
analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle. PLOS ONE 7(10):e47348
98. Rooney LM, AmosWB,Hoskisson PA,McConnell G. 2020. Intra-colony channels in E. coli function as
a nutrient uptake system. ISME J. 14(10):2461–73
99. Akturk E, Oliveira H, Santos SB, Costa S, Kuyumcu S, et al. 2019. Synergistic action of phage and
antibiotics: parameters to enhance the killing efficacy against mono and dual-species biofilms.Antibiotics
8(3):103
100. Allers E,Moraru C, Duhaime MB, Beneze E, Solonenko N, et al. 2013. Single-cell and population level
viral infection dynamics revealed by phageFISH, a method to visualize intracellular and free viruses.
Environ. Microbiol. 15(8):2306–18
101. Heilmann S, Sneppen K, Krishna S. 2012. Coexistence of phage and bacteria on the boundary of self-
organized refuges. PNAS 109(31):12828–33
102. Li X,Gonzalez F,EstevesN,Scharf BE,Chen J. 2020.Formation of phage lysis patterns and implications
on co-propagation of phages and motile host bacteria. PLOS Comput. Biol. 16(3):e1007236
103. Ping D,Wang T, Fraebel DT,Maslov S, Sneppen K, Kuehn S. 2020. Hitchhiking, collapse, and contin-
gency in phage infections of migrating bacterial populations. ISME J. 14(8):2007–18
104. Eriksen RS, Svenningsen SL, Sneppen K, Mitarai N. 2017. A growing microcolony can survive and
support persistent propagation of virulent phages. PNAS 115(2):337–42
105. Simmons M, Drescher K, Nadell CD, Bucci V. 2018. Phage mobility is a core determinant of phage-
bacteria coexistence in biofilms. ISME J. 12(2):532–43
106. Fernández L,GutiérrezD,García P,Rodríguez A.2021.Environmental pH is a keymodulator of Staphy-
lococcus aureus biofilm development under predation by the virulent phage phiIPLA-RODI. ISME J.
15(1):245–59
107. Hartmann R, Jeckel H, Jelli E, Singh PK, Vaidya S, et al. 2021. Quantitative image analysis of microbial
communities with BiofilmQ.Nat. Microbiol. 6(2):151–56
108. Lebeaux D, Ghigo J-M, Beloin C. 2014. Biofilm-related infections: bridging the gap between clini-
cal management and fundamental aspects of recalcitrance toward antibiotics. Microbiol. Mol. Biol. Rev.
78(3):510–43
109. TanD,Zhang Y,ChengM,Le S,Gu J, et al. 2019.Characterization ofKlebsiella pneumoniae ST11 isolates
and their interactions with lytic phages. Viruses 11(11):1080
110. Oechslin F. 2018. Resistance development to bacteriophages occurring during bacteriophage therapy.
Viruses 10(7):351

























































































111. Olszak T, Danis-Wlodarczyk K, Arabski M, Gula G,Maciejewska B, et al. 2019. Pseudomonas aeruginosa
PA5oct jumbo phage impacts planktonic and biofilm population and reduces its host virulence. Viruses
11(12):1089
112. Chan BK, Abedon ST, Loc-Carrillo C. 2013. Phage cocktails and the future of phage therapy. Future
Microbiol. 8(6):769–83
113. Morris JL, Letson HL, Elliott L, Grant AL, Wilkinson M, et al. 2019. Evaluation of bacteriophage as
an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus. PLOS
ONE 14(12):e0226574
114. Verma V, Harjai K, Chhibber S. 2009. Restricting ciprofloxacin-induced resistant variant formation
in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J. Antimicrob.
Chemother. 64(6):1212–18
115. Burmeister AR, Fortier A, Roush C, Lessing AJ, Bender RG, et al. 2020. Pleiotropy complicates a trade-
off between phage resistance and antibiotic resistance. PNAS 117(21):11207–16
116. Seth AK, Geringer MR, Nguyen KT, Agnew SP, Dumanian Z, et al. 2013. Bacteriophage therapy for
Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast. Reconstr.
Surg. 131:225–34
117. Patey O,McCallin S,Mazure H, Liddle M, Smithyman A, Dublanchet A. 2019. Clinical indications and
compassionate use of phage therapy: personal experience and literature review with a focus on osteoar-
ticular infections. Viruses 11(1):18
118. Francolini I, Donelli G. 2010. Prevention and control of biofilm-based medical-device-related infec-
tions. FEMS Immunol. Med. Microbiol. 59(3):227–38
119. Curtin JJ, Donlan RM. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms
by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50(4):1268–75
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